Q9UKC9 (FBXL2_HUMAN) Reviewed, UniProtKB/Swiss-Prot
Last modified
May 1, 2013.
Version 105.
History...
Names·Attributes·General annotation·Ontologies·Alt products·Sequence annotation·Sequences·References·Cross-refs·Entry info·DocumentsCustomize order
Names·Attributes·General annotation·Ontologies·Alt products·Sequence annotation·Sequences·References·Cross-refs·Entry info·DocumentsCustomize orderNames and origin
| Protein names | Recommended name: F-box/LRR-repeat protein 2 Alternative name(s): F-box and leucine-rich repeat protein 2 F-box protein FBL2/FBL3 | ||||
| Gene names |
| ||||
| Organism | Homo sapiens (Human) [Reference proteome] | ||||
| Taxonomic identifier | 9606 [NCBI] | ||||
| Taxonomic lineage | Eukaryota › Metazoa › Chordata › Craniata › Vertebrata › Euteleostomi › Mammalia › Eutheria › Euarchontoglires › Primates › Haplorrhini › Catarrhini › Hominidae › Homo![]() |
Protein attributes
| Sequence length | 423 AA. |
| Sequence status | Complete. |
| Protein existence | Evidence at protein level |
General annotation (Comments)
| Function | Calcium-activated substrate recognition component of a SCF (SKP1-cullin-F-box protein) E3 ubiquitin-protein ligase complex which mediates the ubiquitination and subsequent proteasomal degradation of target proteins. Unlike many F-box proteins, FBXL2 doesn't seem to target phosphodegron within its substrates but rather calmodulin-binding motifs. Targets PCYT1A for its monoubiquitination and degradation, this is antagonized by calmodulin By similarity. Targets the cyclins CCND2 and CCND3 for polyubiquitination and degradation, leading to cell-cycle arrest in G0, also antagonized by calmodulin. Binds to hepatitis C virus non-structural protein 5A (NS5A) in a reaction crucial for hepatitis C virus RNA replication. Ref.9 Ref.10 Ref.11 |
| Subunit structure | Interacts with SKP1. Interacts with PCYT1A. Part of a SCF (SKP1-cullin-F-box) protein ligase complex By similarity. Interacts (via CAAX motif) with hepatitis C virus non-structural protein 5A (NS5A). May also interact, but less efficiently, with hepatitis C virus non-structural protein 5B (NS5B). Interacts with CCND2 and CCND3. Ref.2 Ref.9 Ref.10 Ref.11 |
| Subcellular location | |
| Tissue specificity | Expressed in brain, heart, kidney, liver, lung, pancreas and placenta. Ref.2 |
| Miscellaneous | Deletion of the F-box domain creates a dominant-negative protein that inhibits replication of hepatitis C virus RNA when overexpressed in a hepatoma cell line; this inhibition could be overcome by NS5A coexpression. |
| Sequence similarities | Contains 1 F-box domain. Contains 13 LRR (leucine-rich) repeats. |
| Sequence caution | The sequence AAF03128.1 differs from that shown. Reason: Erroneous initiation. |
Ontologies
| Keywords | |
|---|---|
| Biological process | Host-virus interaction Ubl conjugation pathway |
| Cellular component | Membrane |
| Coding sequence diversity | Alternative splicing Polymorphism |
| Domain | Leucine-rich repeat Repeat |
| Ligand | Calcium Calmodulin-binding |
| PTM | Lipoprotein Prenylation |
| Technical term | Complete proteome Reference proteome |
| Gene Ontology (GO) | |
| Biological_process | protein monoubiquitination Inferred from electronic annotation. Source: Compara proteolysisTraceable author statement Ref.1. Source: ProtInc ubiquitin-dependent protein catabolic processInferred from electronic annotation. Source: Compara virus-host interactionInferred from electronic annotation. Source: UniProtKB-KW |
| Cellular_component | cytoplasm Traceable author statement PubMed 10508920. Source: ProtInc membraneInferred from direct assay Ref.9. Source: UniProtKB |
| Molecular_function | ubiquitin-protein ligase activity Traceable author statement Ref.2. Source: ProtInc |
| Complete GO annotation... | |
Alternative products
| This entry describes 2 isoforms produced by alternative splicing. [Align] [Select] | ||||||
| Isoform 1 (identifier: Q9UKC9-1) This isoform has been chosen as the 'canonical' sequence. All positional information in this entry refers to it. This is also the sequence that appears in the downloadable versions of the entry. | ||||||
| Isoform 2 (identifier: Q9UKC9-2) The sequence of this isoform differs from the canonical sequence as follows: 132-199: Missing. | ||||||
| Note: No experimental confirmation available. |
Sequence annotation (Features)
| Feature key | Position(s) | Length | Description | Graphical view | Feature identifier | ||||
Molecule processing | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Chain | 1 – 423 | 423 | F-box/LRR-repeat protein 2 | PRO_0000119840 | |||||
Regions | |||||||||
| Domain | 9 – 55 | 47 | F-box | ||||||
| Repeat | 61 – 87 | 27 | LRR 1 | ||||||
| Repeat | 88 – 113 | 26 | LRR 2 | ||||||
| Repeat | 114 – 139 | 26 | LRR 3 | ||||||
| Repeat | 140 – 165 | 26 | LRR 4 | ||||||
| Repeat | 166 – 191 | 26 | LRR 5 | ||||||
| Repeat | 192 – 217 | 26 | LRR 6 | ||||||
| Repeat | 218 – 243 | 26 | LRR 7 | ||||||
| Repeat | 244 – 269 | 26 | LRR 8 | ||||||
| Repeat | 270 – 295 | 26 | LRR 9 | ||||||
| Repeat | 296 – 321 | 26 | LRR 10 | ||||||
| Repeat | 322 – 350 | 29 | LRR 11 | ||||||
| Repeat | 351 – 375 | 25 | LRR 12 | ||||||
| Repeat | 376 – 401 | 26 | LRR 13 | ||||||
| Region | 80 – 90 | 11 | Interaction with Calmodulin By similarity | ||||||
| Motif | 420 – 423 | 4 | CAAX motif | ||||||
Amino acid modifications | |||||||||
| Lipidation | 420 | 1 | S-geranylgeranyl cysteine Probable | ||||||
Natural variations | |||||||||
| Alternative sequence | 132 – 199 | 68 | Missing in isoform 2. | VSP_044600 | |||||
| Natural variant | 226 | 1 | V → M in a colorectal cancer sample; somatic mutation. Ref.12 | VAR_036071 | |||||
Experimental info | |||||||||
| Mutagenesis | 420 | 1 | C → S: Loss of geranylgeranylation and association to membranes. Ref.9 | ||||||
| Sequence conflict | 62 | 1 | T → I in AAF04510. Ref.1 | ||||||
| Sequence conflict | 62 | 1 | T → I in AAF03128. Ref.2 | ||||||
| Sequence conflict | 62 | 1 | T → I in CAG33402. Ref.5 | ||||||
| Sequence conflict | 77 | 1 | G → V in AAF04510. Ref.1 | ||||||
| Sequence conflict | 81 | 1 | R → K in BAA91691. Ref.4 | ||||||
| Sequence conflict | 108 | 1 | H → Q in BAG61062. Ref.4 | ||||||
| Sequence conflict | 174 | 1 | I → W in CAB43222. Ref.8 | ||||||
| Sequence conflict | 320 | 1 | S → P in CAB43222. Ref.8 | ||||||
| Sequence conflict | 342 | 1 | R → G in CAG33402. Ref.5 | ||||||
Sequences
| ||||||||||||||||||||||||
References
| « Hide 'large scale' references | |
| [1] | "Identification of a family of human F-box proteins." Cenciarelli C., Chiaur D.S., Guardavaccaro D., Parks W., Vidal M., Pagano M. Curr. Biol. 9:1177-1179(1999) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1). |
| [2] | "A family of mammalian F-box proteins." Winston J.T., Koepp D.M., Zhu C., Elledge S.J., Harper J.W. Curr. Biol. 9:1180-1182(1999) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), INTERACTION WITH SKP1, TISSUE SPECIFICITY. |
| [3] | "cDNA cloning and expression analysis of new members of the mammalian F-box protein family." Ilyin G.P., Rialland M., Pigeon C., Guguen-Guillouzo C. Genomics 67:40-47(2000) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1). |
| [4] | "Complete sequencing and characterization of 21,243 full-length human cDNAs." Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R., Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H., Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S. Sugano S.Nat. Genet. 36:40-45(2004) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 2). |
| [5] | "Cloning of human full open reading frames in Gateway(TM) system entry vector (pDONR201)." Ebert L., Schick M., Neubert P., Schatten R., Henze S., Korn B. Submitted (JUN-2004) to the EMBL/GenBank/DDBJ databases Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1). |
| [6] | "The DNA sequence, annotation and analysis of human chromosome 3." Muzny D.M., Scherer S.E., Kaul R., Wang J., Yu J., Sudbrak R., Buhay C.J., Chen R., Cree A., Ding Y., Dugan-Rocha S., Gill R., Gunaratne P., Harris R.A., Hawes A.C., Hernandez J., Hodgson A.V., Hume J. Gibbs R.A.Nature 440:1194-1198(2006) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. |
| [7] | "The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC)." The MGC Project Team Genome Res. 14:2121-2127(2004) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1). Tissue: Brain. |
| [8] | "The full-ORF clone resource of the German cDNA consortium." Bechtel S., Rosenfelder H., Duda A., Schmidt C.P., Ernst U., Wellenreuther R., Mehrle A., Schuster C., Bahr A., Bloecker H., Heubner D., Hoerlein A., Michel G., Wedler H., Koehrer K., Ottenwaelder B., Poustka A., Wiemann S., Schupp I. BMC Genomics 8:399-399(2007) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 174-423 (ISOFORM 1). Tissue: Brain. |
| [9] | "Identification of FBL2 as a geranylgeranylated cellular protein required for hepatitis C virus RNA replication." Wang C., Gale M. Jr., Keller B.C., Huang H., Brown M.S., Goldstein J.L., Ye J. Mol. Cell 18:425-434(2005) [PubMed] [Europe PMC] [Abstract] Cited for: FUNCTION, INTERACTION WITH HEPATITIS C VIRUS NS5A, ISOPRENYLATION AT CYS-420, MUTAGENESIS OF CYS-420, SUBCELLULAR LOCATION. |
| [10] | "F-box protein FBXL2 targets cyclin D2 for ubiquitination and degradation to inhibit leukemic cell proliferation." Chen B.B., Glasser J.R., Coon T.A., Zou C., Miller H.L., Fenton M., McDyer J.F., Boyiadzis M., Mallampalli R.K. Blood 119:3132-3141(2012) [PubMed] [Europe PMC] [Abstract] Cited for: FUNCTION, INTERACTION WITH CCND2. |
| [11] | "F-box protein FBXL2 exerts human lung tumor suppressor-like activity by ubiquitin-mediated degradation of cyclin D3 resulting in cell cycle arrest." Chen B.B., Glasser J.R., Coon T.A., Mallampalli R.K. Oncogene 31:2566-2579(2012) [PubMed] [Europe PMC] [Abstract] Cited for: FUNCTION, INTERACTION WITH CCND3. |
| [12] | "The consensus coding sequences of human breast and colorectal cancers." Sjoeblom T., Jones S., Wood L.D., Parsons D.W., Lin J., Barber T.D., Mandelker D., Leary R.J., Ptak J., Silliman N., Szabo S., Buckhaults P., Farrell C., Meeh P., Markowitz S.D., Willis J., Dawson D., Willson J.K.V. Velculescu V.E.Science 314:268-274(2006) [PubMed] [Europe PMC] [Abstract] Cited for: VARIANT [LARGE SCALE ANALYSIS] MET-226. |
| + | Additional computationally mapped references. |
Cross-references
Sequence databases | |
|---|---|
| EMBL GenBank DDBJ | AF174589 mRNA. Translation: AAF04510.1. AF176518 mRNA. Translation: AAF03128.1. Different initiation. AF186273 mRNA. Translation: AAD56248.1. AK001438 mRNA. Translation: BAA91691.1. AK298967 mRNA. Translation: BAG61062.1. CR457121 mRNA. Translation: CAG33402.1. AC122176 Genomic DNA. No translation available. AC123900 Genomic DNA. No translation available. BC031556 mRNA. Translation: AAH31556.1. AL049953 mRNA. Translation: CAB43222.1. |
| IPI | IPI00296850. IPI00923623. |
| PIR | T08680. |
| RefSeq | NP_001165184.1. NM_001171713.1. NP_036289.3. NM_012157.3. |
| UniGene | Hs.475872. |
3D structure databases | |
| ProteinModelPortal | Q9UKC9. |
| ModBase | Search... |
Protein-protein interaction databases | |
| IntAct | Q9UKC9. 4 interactions. |
| MINT | MINT-1390736. |
| STRING | 9606.ENSP00000417601. |
Polymorphism databases | |
| DMDM | 145559475. |
Proteomic databases | |
| PaxDb | Q9UKC9. |
| PRIDE | Q9UKC9. |
Protocols and materials databases | |
| DNASU | 25827. |
| StructuralBiologyKnowledgebase | Search... |
Genome annotation databases | |
| Ensembl | ENST00000484457; ENSP00000417601; ENSG00000153558. ENST00000507198; ENSP00000426163; ENSG00000153558. ENST00000538892; ENSP00000441228; ENSG00000153558. |
| GeneID | 25827. |
| KEGG | hsa:25827. |
| UCSC | uc003cfp.3. human. |
Organism-specific databases | |
| CTD | 25827. |
| GeneCards | GC03P033293. |
| HGNC | HGNC:13598. FBXL2. |
| MIM | 605652. gene. |
| neXtProt | NX_Q9UKC9. |
| PharmGKB | PA28021. |
| GenAtlas | Search... |
Phylogenomic databases | |
| eggNOG | NOG300245. |
| HOGENOM | HOG000230659. |
| HOVERGEN | HBG051586. |
| InParanoid | Q9UKC9. |
| KO | K10268. |
| OMA | LTENVFG. |
| OrthoDB | EOG4KPTB9. |
| PhylomeDB | Q9UKC9. |
Gene expression databases | |
| ArrayExpress | Q9UKC9. |
| Bgee | Q9UKC9. |
| CleanEx | HS_FBXL2. |
| Genevestigator | Q9UKC9. |
| GermOnline | ENSG00000153558. Homo sapiens. |
Family and domain databases | |
| InterPro | IPR001810. F-box_dom_cyclin-like. IPR006553. Leu-rich_rpt_Cys-con_subtyp. [Graphical view] |
| Pfam | PF00646. F-box. 1 hit. [Graphical view] |
| SMART | SM00256. FBOX. 1 hit. SM00367. LRR_CC. 2 hits. [Graphical view] |
| PROSITE | PS50181. FBOX. 1 hit. [Graphical view] |
| ProtoNet | Search... |
Other | |
| ChiTaRS | FBXL2. human. |
| GenomeRNAi | 25827. |
| NextBio | 47109. |
| SOURCE | Search... |
Entry information
| Entry name | FBXL2_HUMAN | ||||||||
| Accession | Primary (citable) accession number: Q9UKC9 Secondary accession number(s): B4DQV0 Q9Y3Y9 | ||||||||
| Entry history |
| ||||||||
| Entry status | Reviewed (UniProtKB/Swiss-Prot) | ||||||||
| Annotation program | Chordata Protein Annotation Program | ||||||||
| Disclaimer | Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. It is not in any way intended to be used as a substitute for professional medical advice, diagnosis, treatment or care. | ||||||||
Relevant documents
| Human chromosome 3 Human chromosome 3: entries, gene names and cross-references to MIM |
| Human entries with polymorphisms or disease mutations List of human entries with polymorphisms or disease mutations |
| Human polymorphisms and disease mutations Index of human polymorphisms and disease mutations |
| MIM cross-references Online Mendelian Inheritance in Man (MIM) cross-references in UniProtKB/Swiss-Prot |
| SIMILARITY comments Index of protein domains and families |

Clusters with
